Search - tctmd.com

Displaying 101 - 120 of 1851

Sort: Relevancy | Date

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

January 09, 2025

Just One in Five Grand Rounds Lectures Given by Women

News Daily News

Just One in Five Grand Rounds Lectures Given by Women

Michael O'Riordan

January 07, 2025

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

TCTMD’s Biggest News of 2024: Stories, Videos, and More

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

January 01, 2025

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

December 27, 2024

Top Coronary Artery Disease News in 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

Some Guidance for Managing Patients With AS and CAD: Review

News Daily News

Some Guidance for Managing Patients With AS and CAD: Review

Yael L. Maxwell

December 24, 2024

BMJ Investigation Revives Questions About PLATO, Ticagrelor

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

December 20, 2024

Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3

News Daily News

Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3

December 09, 2024

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

December 06, 2024

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

News Daily News

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Yael L. Maxwell

December 05, 2024

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

December 04, 2024

TCTMD’s Top 10 Most Popular Stories for November 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

December 03, 2024

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

November 14, 2024

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

News Daily News

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Yael L. Maxwell

November 14, 2024

TCTMD’s Top 10 Most Popular Stories for October 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

November 01, 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.